Cytoplasmic accumulation of connexin32 expands cancer stem cell population in human HuH7 hepatoma cells by enhancing its self-renewal

International Journal of Cancer

Volumn 128, Issue 1, 2011, Pages 51-62

  Kawasaki, Yohei ^a   Omori, Yasufumi ^a   Li, Qingchang ^a,b   Nishikawa, Yuji ^a   Yoshioka, Toshiaki ^a   Yoshida, Masayuki ^a   Ishikawa, Kazuo ^a   Enomoto, Katsuhiko ^a  

^a AKITA UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cell; Connexin32; Gap junction; Hepatocellular carcinoma; Tet off system

Indexed keywords

CONNEXIN 32;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL MATURATION; CELL POPULATION; CELL RENEWAL; CELL SIZE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; FLUORESCENCE ACTIVATED CELL SORTING; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CONNEXINS; CYTOPLASM; DOXYCYCLINE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; TETRACYCLINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 78349283937     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25308     Document Type: Article

References (49)

1. Bruzzone R, White TW, Paul DL,. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 1996; 238: 1 27.
2. Beyer EC, Berthoud VM,. The family of connexin genes. In:, Harris AL, Locke D, eds. Connexins. New York: Humana Press, 2009. 3 26.
3. Sohl G, Willecke K,. An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes 2003; 10: 173 80.
4. Anand RJ, Hackam DJ,. The role of gap junctions in health and disease. Crit Care Med 2005; 33: S535 S538.
5. Leithe E, Sirnes S, Omori Y, Rivedal E,. Downregulation of gap junctions in cancer cells. Crit Rev Oncog 2006; 12: 225 56.
6. Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML,. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 2005; 1719: 125 45.
7. Ito A, Katoh F, Kataoka TR, Okada M, Tsubota N, Asada H, Yoshikawa K, Maeda S, Kitamura Y, Yamasaki H, Nojima H,. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest 2000; 105: 1189 97.
8. Ito A, Koma Y, Uchino K, Okada T, Ohbayashi C, Tsubota N, Okada M,. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis. Cancer Lett 2006; 234: 239 48.
9. Nicholson B, Dermietzel R, Teplow D, Traub O, Willecke K, Revel JP,. Two homologous protein components of hepatic gap junctions. Nature 1987; 329: 732 4.
10. Vinken M, Henkens T, De Rop E, Fraczek J, Vanhaecke T, Rogiers V,. Biology and pathobiology of gap junctional channels in hepatocytes. Hepatology 2008; 47: 1077 88.
11. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon AM, Mesnil M, Berger F, Partensky C, Yamasaki H,. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 1994; 56: 87 94.
12. Omori Y, Krutovskikh V, Mironov N, Tsuda H, Yamasaki H,. Cx32 gene mutation in a chemically induced rat liver tumour. Carcinogenesis 1996; 17: 2077 80.
13. Inose T, Kato H, Kimura H, Faried A, Tanaka N, Sakai M, Sano A, Sohda M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, et al. Correlation between connexin 26 expression and poor prognosis of esophageal squamous cell carcinoma. Ann Surg Oncol 2009; 16: 1704 10.
14. Jamieson S, Going JJ, D'Arcy R, George WD,. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J Pathol 1998; 184: 37 43.
15. Kanczuga-Koda L, Sulkowski S, Lenczewski A, Koda M, Wincewicz A, Baltaziak M, Sulkowska M,. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol 2006; 59: 429 33.
16. Mehta PP, Perez-Stable C, Nadji M, Mian M, Asotra K, Roos BA,. Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genet 1999; 24: 91 110.
17. Oyamada M, Krutovskikh VA, Mesnil M, Partensky C, Berger F, Yamasaki H,. Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: increased expression of cardiac-type gap junction gene connexin 43. Mol Carcinog 1990; 3: 273 8.
18. Li Q, Omori Y, Nishikawa Y, Yoshioka T, Yamamoto Y, Enomoto K,. Cytoplasmic accumulation of connexin32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo. Int J Cancer 2007; 121: 536 46.
19. Fialkow PJ, Gartler SM, Yoshida A,. Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci USA 1967; 58: 1468 71.
20. Furth J, Kahn MC,. The transmission of leukemia of mice with a single cell. Am J Cancer 1937; 31: 276 82.
21. Jordan CT, Guzman ML, Noble M,. Cancer stem cells. N Engl J Med 2006; 355: 1253 61.
22. Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M,. Cancer stem cell markers in common cancers therapeutic implications. Trends Mol Med 2008; 14: 450 60.
23. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H,. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006; 44: 240 51.
24. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J,. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 3858 63.
25. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C,. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313 23.
26. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704 15.
27. Gossen M, Bujard H,. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547 51.
28. Falciatori I, Borsellino G, Haliassos N, Boitani C, Corallini S, Battistini L, Bernardi G, Stefanini M, Vicini E,. Identification and enrichment of spermatogonial stem cells displaying side-population phenotype in immature mouse testis. FASEB J 2004; 18: 376 8.
29. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC,. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797 806.
30. Shimano K, Satake M, Okaya A, Kitanaka J, Kitanaka N, Takemura M, Sakagami M, Terada N, Tsujimura T,. Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J Pathol 2003; 163: 3 9.
31. Grichnik JM, Burch JA, Schulteis RD, Shan S, Liu J, Darrow TL, Vervaert CE, Seigler HF,. Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol 2006; 126: 142 53.
32. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA, Brenner MK,. A distinct side population of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004; 101: 14228 33.
33. Kondo T, Setoguchi T, Taga T,. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004; 101: 781 6.
34. Moserle L, Indraccolo S, Ghisi M, Frasson C, Fortunato E, Canevari S, Miotti S, Tosello V, Zamarchi R, Corradin A, Minuzzo S, Rossi E, et al. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res 2008; 68: 5658 68.
35. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK,. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 2006; 103: 11154 9.
36. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH,. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 2007; 67: 3716 24.
37. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY,. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132: 2542 56.
38. + hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 2006; 351: 820 4.
39. Kondo T,. Stem cell-like cancer cells in cancer cell lines. Cancer Biomark 2007; 3: 245 50.
40. + cancer stem cells in human solid tumours. PLoS One 2008; 3: e3469.
41. Omori Y, Li Q, Nishikawa Y, Yoshioka T, Yoshida M, Nishimura T, Enomoto K,. Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression. J Membr Biol 2007; 218: 73 7.
42. Hsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G, Klein CA,. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13: 58 68.
43. Riethdorf S, Wikman H, Pantel K,. Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 2008; 123: 1991 2006.
44. Hill RP, Perris R,. Destemming cancer stem cells. J Natl Cancer Inst 2007; 99: 1435 40.
45. Chiba T, Miyagi S, Saraya A, Aoki R, Seki A, Morita Y, Yonemitsu Y, Yokosuka O, Taniguchi H, Nakauchi H, Iwama A,. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res 2008; 68: 7742 9.
46. Feng D, Peng C, Li C, Zhou Y, Li M, Ling B, Wei H, Tian Z,. Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncol Rep 2009; 22: 1129 34.
47. Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Takakura Y,. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol 2009; 34: 1381 6.
48. Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN,. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009; 8: 3274 84.
49. Saiki Y, Ishimaru S, Mimori K, Takatsuno Y, Nagahara M, Ishii H, Yamada K, Mori M,. Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells. Ann Surg Oncol 2009; 16: 2638 44.